PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy | Journal for ImmunoTherapy of Cancer
Frontiers | Expression of Programmed Death-Ligand 1 by Human Colonic CD90+ Stromal Cells Differs Between Ulcerative Colitis and Crohn's Disease and Determines Their Capacity to Suppress Th1 Cells
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer? - ScienceDirect